These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2302601)

  • 1. Desmopressin: do we now know its role?
    Tyers GF
    Can J Surg; 1990 Feb; 33(1):5-6. PubMed ID: 2302601
    [No Abstract]   [Full Text] [Related]  

  • 2. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.
    Hackmann T; Gascoyne RD; Naiman SC; Growe GH; Burchill LD; Jamieson WR; Sheps SB; Schechter MT; Townsend GE
    N Engl J Med; 1989 Nov; 321(21):1437-43. PubMed ID: 2682243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.
    Salzman EW; Weinstein MJ; Weintraub RM; Ware JA; Thurer RL; Robertson L; Donovan A; Gaffney T; Bertele V; Troll J
    N Engl J Med; 1986 May; 314(22):1402-6. PubMed ID: 3517650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial.
    Hedderich GS; Petsikas DJ; Cooper BA; Leznoff M; Guerraty AJ; Poirier NL; Symes JF; Morin JE
    Can J Surg; 1990 Feb; 33(1):33-6. PubMed ID: 2405964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin acetate to reduce blood loss after cardiac surgery.
    N Engl J Med; 1986 Sep; 315(13):834-5. PubMed ID: 3748099
    [No Abstract]   [Full Text] [Related]  

  • 6. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
    Castaman G; Rodeghiero F
    Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
    Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
    Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin and bleeding.
    Bidstrup BP; Royston D
    Anaesthesia; 1989 Dec; 44(12):1009. PubMed ID: 2619003
    [No Abstract]   [Full Text] [Related]  

  • 10. Desmopressin acetate in postoperative bleeding.
    Smith RC
    DICP; 1990 May; 24(5):475-6. PubMed ID: 2188433
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological therapies to minimise platelet transfusion.
    Norfolk DR; Seghatchian J
    Transfus Sci; 2000 Jun; 22(3):149-53. PubMed ID: 10831916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
    Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
    Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children.
    Seear MD; Wadsworth LD; Rogers PC; Sheps S; Ashmore PG
    J Thorac Cardiovasc Surg; 1989 Aug; 98(2):217-9. PubMed ID: 2666759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin-related myocardial infarction in a patient with Wegener's granulomatosis: a case report and review of the literature.
    Pape E; Béné J; Buchdahl AL; Gautier S; Hatron PY; Lambert M
    J Mal Vasc; 2013 Feb; 38(1):43-6. PubMed ID: 23265678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of desmopressin in open-heart surgery.
    Cattaneo M
    Haemophilia; 2008 Jan; 14 Suppl 1():40-7. PubMed ID: 18173693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy.
    Wieding JU; Matern J; Köstering H; Wermes C; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):441-8. PubMed ID: 16149022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Venous thrombosis of the lower limbs and pulmonary embolism after desmopressin: a coincidence or a pathogenetic role?].
    Pentimone F; Del Corso L
    Clin Ter; 1991 Oct 15-31; 139(1-2):49-51. PubMed ID: 1837767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
    Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z
    Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.